We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$472B
AUM Growth
+$3.53B
Cap. Flow
-$5.2B
Cap. Flow %
-1.1%
Top 10 Hldgs %
16.24%
Holding
2,596
New
95
Increased
1,094
Reduced
954
Closed
84

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.2B
2
AGN
Allergan plc
AGN
+$1.03B
3
GILD icon
Gilead Sciences
GILD
+$917M
4
PFE icon
Pfizer
PFE
+$901M
5
NKE icon
Nike
NKE
+$872M

Sector Composition

Rank Sector Weight
1 Healthcare 19.88%
2 Consumer Discretionary 14.86%
3 Financials 14.2%
4 Technology 12.51%
5 Industrials 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MIDD icon
251
Middleby
MIDD
$5.43B
$414M 0.09%
3,589,090
-27,470
-0.8% -$3.15M
ODFL icon
252
Old Dominion Freight Line
ODFL
$43.4B
$412M 0.09%
20,511,282
-1,178,823
-5% -$25.2M
CAG icon
253
Conagra Brands
CAG
$7.14B
$410M 0.09%
11,027,483
-1,649,855
-13% -$58.8M
WCG
254
DELISTED
Wellcare Health Plans, Inc.
WCG
$409M 0.09%
3,807,873
-553,820
-13% -$54.2M
EQR icon
255
Equity Residential
EQR
$24.4B
$408M 0.09%
5,919,497
+145,550
+3% +$10M
HAR
256
DELISTED
Harman International Industries
HAR
$404M 0.09%
5,630,763
+3,385,803
+151% +$264M
TSRO
257
DELISTED
TESARO, Inc.
TSRO
$404M 0.09%
4,807,570
+423,466
+10% +$18.9M
WUBA
258
DELISTED
58.com Inc
WUBA
$403M 0.09%
8,781,211
+2,730,525
+45% +$141M
SLG icon
259
SL Green Realty
SLG
$3.95B
$402M 0.09%
3,904,169
+268,605
+7% +$26.4M
CHH icon
260
Choice Hotels
CHH
$4.62B
$402M 0.09%
8,449,079
-356,869
-4% -$17.3M
EMR icon
261
Emerson Electric
EMR
$91.7B
$400M 0.08%
7,661,766
-436,809
-5% -$23.2M
ABBV icon
262
AbbVie
ABBV
$442B
$399M 0.08%
6,448,950
-1,387,886
-18% -$84.6M
INTC icon
263
Intel
INTC
$493B
$398M 0.08%
12,137,343
+36,294
+0.3% +$1.14M
PFPT
264
DELISTED
Proofpoint, Inc.
PFPT
$396M 0.08%
6,276,914
+342,433
+6% +$19.6M
SBAC icon
265
SBA Communications
SBAC
$19.3B
$396M 0.08%
3,665,290
+775,322
+27% +$78.6M
NEM icon
266
Newmont
NEM
$124B
$394M 0.08%
10,068,217
-247,280
-2% -$8.19M
CLGX
267
DELISTED
Corelogic, Inc.
CLGX
$388M 0.08%
10,077,043
+26,120
+0.3% +$954K
WWAV
268
DELISTED
The WhiteWave Foods Company
WWAV
$385M 0.08%
8,204,837
+206,249
+3% +$8.86M
EA
269
DELISTED
Electronic Arts
EA
$385M 0.08%
5,080,420
+433,121
+9% +$30.5M
BSMX
270
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
$384M 0.08%
42,199,117
-1,264,300
-3% -$11.2M
LII icon
271
Lennox International
LII
$14.9B
$383M 0.08%
2,686,718
+78,162
+3% +$10.7M
SHW icon
272
Sherwin-Williams
SHW
$88.5B
$374M 0.08%
3,819,732
-278,658
-7% -$27.1M
VNO icon
273
Vornado Realty Trust
VNO
$7.24B
$373M 0.08%
4,613,818
-126,653
-3% -$9.82M
TEAM icon
274
Atlassian
TEAM
$39.1B
$371M 0.08%
14,343,506
+813,379
+6% +$19.3M
KSS icon
275
Kohl's
KSS
$2.1B
$369M 0.08%
9,739,020
+4,012
+0% +$159K

Similar funds

T. Rowe Price Associates's Q2 2016 Portfolio in Review

As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
  • T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
  • T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
  • T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
  • T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
  • T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.

Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.